Ryan Allway
November 13th, 2018
Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), would like to update shareholders on its operations in Mexico. On October 30, 2018, regulations for CBD products were published by COFEPRIS. The regulations include that products made from hemp are industrial products that can be traded as cosmetics, supplement foods and herbal products. CBD medicines were also included in the regulations and will require clinicals and proper protocols.
Isodiol established operations in Mexico in 2017 and has since signed distribution agreements with companies specializing in the distribution of pharmaceutical products across Mexico. The Company has also developed a sales team to cover the government and private sectors for medical, veterinary, laboratory and the cosmetic sales channels. The Company anticipates sales to commence in the first quarter of 2019 and will continue to educate health professionals in the coming months on Isoderm Direct Effect Technology and its approved CBD as an Active Pharmaceutical Ingredient (API) from BSPG Labs, through seminars and associations with a focus on medical conditions including Epilepsy, Parkinson’s and Alzheimer’s.
The Company also applauds US Senator Mitch McConnell for his continued support of the Farm Bill, which is anticipated to fully legalize hemp in the United States for the first time since 1937. Hemp historically has many uses including medicines, clothing, cooking oil, soaps, lotions as well as building materials, animal bedding and biofuels1. “It’s interesting to think about what it could be,” McConnell said. “I don’t want to overstate this, I don’t know whether it’s going to be the next tobacco or not, but I do think it has a lot of potential2,” he added.
On Friday, McConnell announced that completing the work of the new farm bill is one of his top priorities when Congress reconvenes. When discussing the legalization of hemp being included in the Farm Bill, McConnell said, “If there is a Farm Bill, it will be in there, I guarantee that3.” The bill is also anticipated to clarify legality of derivatives such as cannabidiol, also known as CBD, from the hemp plant.
Follow Our Corporate Updates On Facebook: https://www.facebook.com/IsodiolInternationalInc/ and on Twitter: @Isodiolintlinc
About Isodiol International Inc.
Isodiol International Inc. is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions.
Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products. Most recently, the Company received approval for its CBD designated as an Active Pharmaceutical Ingredient for use in Finished Pharmaceutical Products, as was announced on April 26, 2018.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs and continued international expansion into Latin America, Asia, and Europe.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
